![Dámaso Molero](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dámaso Molero
Amministratore Delegato presso 3P Biopharmaceuticals SL
Posizioni attive di Dámaso Molero
Società | Posizione | Inizio | Fine |
---|---|---|---|
3P Biopharmaceuticals SL
![]() 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Amministratore Delegato | 01/04/2007 | - |
Presidente | 16/12/2009 | 30/01/2014 |
Storia della carriera di Dámaso Molero
Precedenti posizioni note di Dámaso Molero
Società | Posizione | Inizio | Fine |
---|---|---|---|
SHIONOGI & CO., LTD. | Corporate Officer/Principal | - | - |
ROCHE HOLDING AG | Corporate Officer/Principal | - | - |
Syntex, Inc. | Corporate Officer/Principal | - | - |
Glaxo, Inc. | Corporate Officer/Principal | - | - |
Formazione di Dámaso Molero
University of Navarra | Masters Business Admin |
Statistiche
Distribuzione geografica
Spagna | 3 |
Canada | 3 |
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Chief Executive Officer | 1 |
President | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Miscellaneous | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ROCHE HOLDING AG | Health Technology |
SHIONOGI & CO., LTD. | Health Technology |
Aziende private | 3 |
---|---|
3P Biopharmaceuticals SL
![]() 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Health Technology |
Glaxo, Inc. | |
Syntex, Inc. | Miscellaneous |
- Borsa valori
- Insiders
- Dámaso Molero
- Esperienza